Tissue macrophage identity and self-renewal

Immunological Reviews

Volumn 262, Issue 1, 2014, Pages 56-73

  Gentek, Rebecca ^a,b   Molawi, Kaaweh ^a,b,c   Sieweke, Michael H ^a,b,c  

^a CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

^b INSERM   (France)

^c MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Macrophage heterogeneity; Macrophage origin; Macrophage proliferation; Macrophage self renewal; Macrophage tissue specific identity

Indexed keywords

ANIMAL; ANTIBODY SPECIFICITY; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOLOGY; HUMAN; IMMUNOLOGY; MACROPHAGE; METABOLISM; PHENOTYPE;

ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; HUMANS; MACROPHAGES; ORGAN SPECIFICITY; PHENOTYPE;

EID: 84911077979     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/imr.12224     Document Type: Article

References (159)

1. Metschnikoff E. Allg Ein Med Ztg 1884;27/29:307-332.
2. Metschnikoff E. Virchows Arch 1887;107:209-249.
3. Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, Ley K. Development of monocytes, macrophages, and dendritic cells. Science 2010;327:656-661.
4. Wynn TA, Chawla A, Pollard JW. Macrophage biology in development, homeostasis and disease. Nature 2013;496:445-455.
5. Kohyama M, et al. Role for Spi-C in the development of red pulp macrophages and splenic iron homeostasis. Nature 2009;457:318-321.
6. Gautier EL, et al. Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages. Nat Immunol 2012;13:1118-1128.
7. Nakamura A, et al. Transcription repressor Bach2 is required for pulmonary surfactant homeostasis and alveolar macrophage function. J Exp Med 2013;210:2191-2204.
8. Rosas M, et al. The transcription factor Gata6 links tissue macrophage phenotype and proliferative renewal. Science 2014;14:986-995.
9. Okabe Y, Medzhitov R. Tissue-specific signals control reversible program of localization and functional polarization of macrophages. Cell 2014;157:1-13.
10. Haldar M, et al. Heme-mediated SPI-C induction promotes monocyte differentiation into iron-recycling macrophages. Cell 2014;156:1223-1234.
11. Qiu Y, et al. Eosinophils and type 2 cytokine signaling in macrophages orchestrate development of functional beige fat. Cell 2014;157:1292-1308.
12. Gautier EL, et al. Gata6 regulates aspartoacylase expression in resident peritoneal macrophages and controls their survival. J Exp Med 2014;211:1525-1531.
13. Xue J, et al. Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. Immunity 2014;40:274-288.
14. Ostuni R, et al. Latent enhancers activated by stimulation in differentiated cells. Cell 2013;152:157-171.
15. van Furth R, Cohn Z. The origin and kinetics of mononuclear phagocytes. J Exp Med 1968;128:415-435.
16. Ginhoux F, et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 2010;330:841-845.
17. Schulz C, et al. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science 2012;336:86-90.
18. Hoeffel G, et al. Adult Langerhans cells derive predominantly from embryonic fetal liver monocytes with a minor contribution of yolk sac-derived macrophages. J Exp Med 2012;209:1167-1181.
19. Yona S, et al. Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity 2013;38:79-91.
20. Hashimoto D, et al. Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes. Immunity 2013;38:792-804.
21. Bain CC, et al. Resident and pro-inflammatory macrophages in the colon represent alternative context-dependent fates of the same Ly6Chi monocyte precursors. Mucosal Immunol 2013;6:498-510.
22. Zigmond E, et al. Ly6C hi monocytes in the inflamed colon give rise to proinflammatory effector cells and migratory antigen-presenting cells. Immunity 2012;37:1076-1090.
23. Tamoutounour S, et al. Origins and functional specialization of macrophages and of conventional and monocyte-derived dendritic cells in mouse skin. Immunity 2013;39:925-938.
24. Sieweke MH, Allen JE. Beyond stem cells: self-renewal of differentiated macrophages. Science 2013;342:1242974.
25. A-Gonzalez N, et al. The nuclear receptor LXRα controls the functional specialization of splenic macrophages. Nat Immunol 2013;14:831-839.
26. Jojic V, et al. Identification of transcriptional regulators in the mouse immune system. Nat Immunol 2013;14:633-643.
27. Tamoutounour S, et al. CD64 distinguishes macrophages from dendritic cells in the gut and reveals the Th1-inducing role of mesenteric lymph node macrophages during colitis. Eur J Immunol 2012;42:3150-3166.
28. Jakubzick C, et al. Blood monocyte subsets differentially give rise to CD103+ and CD103- pulmonary dendritic cell populations. J Immunol 2008;180:3019-3027.
29. Epelman S, et al. Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during inflammation. Immunity 2014;40:91-104.
30. Jakubzick C, et al. Minimal differentiation of classical monocytes as they survey steady-state tissues and transport antigen to lymph nodes. Immunity 2013;39:599-610.
31. Davies LC, Jenkins SJ, Allen JE, Taylor PR. Tissue-resident macrophages. Nat Immunol 2013;14:986-995.
32. Volkman A, Gowans J. The origin of macrophages from bone marrow in the rat. Br J Exp Pathol 1965;46:62-70.
33. Volkman A. The origin and turnover of mononuclear cells in peritoneal exudates in rats. J Exp Med 1966;124:241-254.
34. Virolainen M. Hematopoietic origin of macrophages as studied by chromosome markers in mice. J Exp Med 1968;127:943-952.
35. Godleski JJ, Brain JD. The origin of alveolar macrophages in mouse radiation chimeras. J Exp Med 1972;136:630-643.
36. Thomas ED, Ramberg RE, Sale GE, Sparkes RS, Golde DW. Direct evidence for a bone marrow origin of the alveolar macrophage in man. Science 1976;192:1016-1018.
37. Sawyer RT, Strausbauch PH, Volkman A. Resident macrophage proliferation in mice depleted of blood monocytes by strontium-89. Lab Invest 1982;46:165-170.
38. Yamada M, Naito M, Takahashi K. Kupffer cell proliferation and glucan-induced granuloma formation in mice depleted of blood monocytes by strontium-89. J Leukoc Biol 1990;47:195-205.
39. Bigley V, et al. The human syndrome of dendritic cell, monocyte, B and NK lymphoid deficiency. J Exp Med 2011;208:227-234.
40. Hambleton S, et al. IRF8 mutations and human dendritic-cell immunodeficiency. N Engl J Med 2011;365:127-138.
41. Golde DW, Finley TN, Cline MJ. The pulmonary macrophage in acute leukemia. N Engl J Med 1974;290:875-878.
42. Cumano A, Godin I. Ontogeny of the hematopoietic system. Annu Rev Immunol 2007;25:745-785.
43. Samokhvalov IM, Samokhvalova NI, Nishikawa S. Cell tracing shows the contribution of the yolk sac to adult haematopoiesis. Nature 2007;446:1056-1061.
44. Kieusseian A, Cumano A. Are hematopoietic stem cells generated in the placenta? Cell Stem Cell 2008;2:197-198.
45. Ueno H, Weissman IL. The origin and fate of yolk sac hematopoiesis: application of chimera analyses to developmental studies. Int J Dev Biol 2010;54:1019-1031.
46. Bertrand JY, Jalil A, Klaine M, Jung S, Cumano A, Godin I. Three pathways to mature macrophages in the early mouse yolk sac. Blood 2005;106:3004-3011.
47. Naito M, et al. Development, differentiation, and phenotypic heterogeneity of murine tissue macrophages. J Leukoc Biol 1996;59:133-138.
48. Mucenski ML, et al. A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell 1991;65:677-689.
49. Sumner R, Crawford A, Mucenski M, Frampton J. Initiation of adult myelopoiesis can occur in the absence of c-Myb whereas subsequent develop-ment is strictly dependent on the transcription factor. Oncogene 2000;19:3335-3342.
50. Soza-Ried C, Hess I, Netuschil N, Schorpp M, Boehm T. Essential role of c-myb in definitive hematopoiesis is evolutionarily conserved. Proc Natl Acad Sci USA 2010;107:17304-17308.
51. Molawi K, et al. Progressive replacement of embryo-derived cardiac macrophages with age. J Exp Med 2014. doi:10.1084/jem.20140639. In press.
52. Ajami B, Bennett JL, Krieger C, Tetzlaff W, Rossi FMV. Local self-renewal can sustain CNS microglia maintenance and function throughout adult life. Nat Neurosci 2007;10:1538-1543.
53. Kierdorf K, et al. Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways. Nat Neurosci 2013;16:273-280.
54. Kennedy DW, Abkowitz JL. Kinetics of central nervous system microglial and macrophage engraftment: analysis using a transgenic bone marrow transplantation model. Blood 1997;90:986-993.
55. Priller J, et al. Targeting gene-modified hematopoietic cells to the central nervous system: use of green fluorescent protein uncovers microglial engraftment. Nat Med 2001;7:1356-1361.
56. Mildner A, et al. Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions. Nat Neurosci 2007;10:1544-1553.
57. Elmore MRPRP, et al. Colony-stimulating factor 1 receptor signaling is necessary for microglia viability, unmasking a microglia progenitor cell in the adult brain. Neuron 2014;82:380-397.
58. Merad M, et al. Langerhans cells renew in the skin throughout life under steady-state conditions. Nat Immunol 2002;3:1135-1141.
59. Chorro L, et al. Langerhans cell (LC) proliferation mediates neonatal development, homeostasis, and inflammation-associated expansion of the epidermal LC network. J Exp Med 2009;206:3089-3100.
60. Satpathy AT, Wu X, Albring JC, Murphy KM. Re(de)fining the dendritic cell lineage. Nat Immunol 2012;13:1145-1154.
61. Landsman L, Varol C, Jung S. Distinct differentiation potential of blood monocyte subsets in the lung. J Immunol 2007;178:2000-2007.
62. Landsman L, Jung S. Lung macrophages serve as obligatory intermediate between blood monocytes and alveolar macrophages. J Immunol 2007;179:3488-3494.
63. Guilliams M, et al. Alveolar macrophages develop from fetal monocytes that differentiate into long-lived cells in the first week of life via GM-CSF. J Exp Med 2013;210:1977-1992.
64. Ginhoux F, Jung S. Monocytes and macrophages: developmental pathways and tissue homeostasis. Nat Rev Immunol 2014;14:392-404.
65. Bogunovic M, et al. Origin of the lamina propria dendritic cell network. Immunity 2009;31:513-525.
66. Varol C, et al. Intestinal lamina propria dendritic cell subsets have different origin and functions. Immunity 2009;31:502-512.
67. Bain CC, et al. Constant replenishment from circulating monocytes maintains the macrophage pool in the intestine of adult mice. Nat Immunol 2014; doi: 10.1038/ni.2967. [Epub ahead of print].
68. Tagliani E, Shi C, Nancy P, Tay C-S, Pamer EG, Erlebacher A. Coordinate regulation of tissue macrophage and dendritic cell population dynamics by CSF-1. J Exp Med 2011;208:1901-1916.
69. Pinto AR, et al. An abundant tissue macrophage population in the adult murine heart with a distinct alternatively-activated macrophage profile. PLoS ONE 2012;7:e36814.
70. Pinto AR, et al. Age-related changes in tissue macrophages precede cardiac functional impairment. Aging 2014;6:399-413.
71. Takayanagi H, et al. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell 2002;3:889-901.
72. Ginhoux F, et al. Langerhans cells arise from monocytes in vivo. Nat Immunol 2006;7:265-273.
73. Ghigo C, et al. Multicolor fate mapping of Langerhans cell homeostasis. J Exp Med 2013;210:1657-1664.
74. Gundra UM, et al. Alternatively activated macrophages derived from monocytes and tissue macrophages are phenotypically and functionally distinct. Blood 2014;123:e110-e122.
75. Jenkins SJ, et al. Local macrophage proliferation, rather than recruitment from the blood, is a signature of TH2 inflammation. Science 2011;332:1284-1288.
76. Davies LC, Rosas M, Smith PJ, Fraser DJ, Jones SA, Taylor PR. A quantifiable proliferative burst of tissue macrophages restores homeostatic macrophage populations after acute inflammation. Eur J Immunol 2011;41:2155-2164.
77. Aziz A, Soucie E, Sarrazin S, Sieweke MH. MafB/c-Maf deficiency enables self-renewal of differentiated functional macrophages. Science 2009;326:867-871.
78. Hume DA, MacDonald KPA. Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling. Blood 2012;119:1810-1820.
79. Pixley FJ, Stanley ER. CSF-1 regulation of the wandering macrophage: complexity in action. Trends Cell Biol 2004;14:628-638.
80. Yoshida H, et al. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 1990;345:442-444.
81. Wiktor-Jedrzejczak W, et al. Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse. Proc Natl Acad Sci USA 1990;87:4828-4832.
82. Van Wesenbeeck L, et al. The osteopetrotic mutation toothless (tl) is a loss-of-function frameshift mutation in the rat Csf1 gene: evidence of a crucial role for CSF-1 in osteoclastogenesis and endochondral ossification. Proc Natl Acad Sci USA 2002;99:14303-14308.
83. Jenkins SJ, et al. IL-4 directly signals tissue-resident macrophages to proliferate beyond homeostatic levels controlled by CSF-1. J Exp Med 2013;210:2477-2491.
84. Davies LC, et al. Distinct bone marrow-derived and tissue-resident macrophage lineages proliferate at key stages during inflammation. Nat Commun 2013;4:1886.
85. Dai XM, et al. Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects. Blood 2002;99:111-120.
86. Wang Y, et al. IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia. Nat Immunol 2012;13:753-760.
87. Greter M, et al. Stroma-derived interleukin-34 controls the development and maintenance of langerhans cells and the maintenance of microglia. Immunity 2012;37:1050-1060.
88. Droin N, Solary E. Editorial: CSF1R, CSF-1, and IL-34, a "menage a trois" conserved across vertebrates. J Leukoc Biol 2010;87:745-747.
89. Garceau V, et al. Pivotal advance: avian colony-stimulating factor 1 (CSF-1), interleukin-34 (IL-34), and CSF-1 receptor genes and gene products. J Leukoc Biol 2010;87:753-764.
90. Chihara T, et al. IL-34 and M-CSF share the receptor Fms but are not identical in biological activity and signal activation. Cell Death Differ 2010;17:1917-1927.
91. Koenen HJPM, Smit MJ, Simmelink MMJA, Schuurman B, Beelen RHJ, Meijer S. Effect of intraperitoneal administration of granulocyte/macrophage-colony-stimulating factor in rats on omental milky-spot composition and tumoricidal activity in vivo and in vitro. Cancer Immunol Immunother 1996;42:310-316.
92. Shibata Y, Berclaz PY, Chroneos ZC, Yoshida M, Whitsett JA, Trapnell BC. GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU.1. Immunity 2001;15:557-567.
93. Fejer G, et al. Nontransformed, GM-CSF-dependent macrophage lines are a unique model to study tissue macrophage functions. Proc Natl Acad Sci USA 2013;110:E2191-E2198.
94. Ito S, Tanaka Y, Nishio N, Thanasegaran S, Isobe K-I. Establishment of self-renewable GM-CSF-dependent immature macrophages in vitro from murine bone marrow. PLoS ONE 2013;8:e76943.
95. Murray PJ, et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity 2014;41:14-20.
96. Spits H, Santo JD. The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. Nat Immunol 2011;12:21-27.
97. Milner JD, et al. Sustained IL-4 exposure leads to a novel pathway for hemophagocytosis, inflammation, and tissue macrophage accumulation. Blood 2010;116:2476-2483.
98. Rückerl D, et al. Induction of IL-4Rα-dependent microRNAs identifies PI3K/Akt signaling as essential for IL-4-driven murine macrophage proliferation in vivo. Blood 2012;120:2307-2316.
99. Nelson MP, et al. IL-33 and M2a alveolar macrophages promote lung defense against the atypical fungal pathogen Pneumocystis murina. J Immunol 2011;186:2372-2381.
100. Lawrence T, Natoli G. Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat Rev Immunol 2011;11:750-761.
101. Satoh T, et al. The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection. Nat Immunol 2010;11:936-944.
102. Arpa L, Valledor AF, Lloberas J, Celada A. IL-4 blocks M-CSF-dependent macrophage proliferation by inducing p21waf1 in a STAT6-dependent way. Eur J Immunol 2009;39:514-526.
103. Mouchemore KA, Pixley FJ. CSF-1 signaling in macrophages: pleiotrophy through phosphotyrosine-based signaling pathways. Crit Rev Clin Lab Sci 2012;49:49-61.
104. Langer SJ, Bortner DM, Roussel MF, Sherr CJ, Ostrowski MC. Mitogenic signaling by colony-stimulating factor 1 and ras is suppressed by the ets-2 DNA-binding domain and restored by myc overexpression. Mol Cell Biol 1992;12:5355-5362.
105. Roussel MF. Signal transduction by the macrophage-colony-stimulating factor receptor (CSF-1R). J Cell Sci Suppl 1994;18:105-108.
106. Roussel MF, Davis JN, Cleveland JL, Ghysdael J, Hiebert SW. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1. Oncogene 1994;9:405-415.
107. Klappacher GW, et al. An induced Ets repressor complex regulates growth arrest during terminal macrophage differentiation. Cell 2002;109:169-180.
108. Sullivan J, Feeley B, Guerra J, Boxer LM. Identification of the major positive regulators of c-myb expression in hematopoietic cells of different lineages. J Biol Chem 1997;272:1943-1949.
109. Graf T. Myb: a transcriptional activator linking proliferation and differentiation in hematopoietic cells. Curr Opin Genet Dev 1992;2:249-255.
110. Roussel MF. Regulation of cell cycle entry and G1 progression by CSF-1. Mol Reprod Dev 1997;46:11-18.
111. Sarrazin S, Sieweke MH. c-Myb as a key player in the control of myeloid cell differentiation. In: Frampton J ed. Myb Transcription Factors: Their Role in Growth, Differentiation and Disease, Vol. 2. The Netherlands: Kluwer Academic Publishers, 2004:133-144.
112. Gewirtz AM, Calabretta B. A c-myb antisense oligodeoxynucleotide inhibits normal human hematopoiesis in vitro. Science 1988;242:1303-1306.
113. Gonda TJ, Buckmaster C, Ramsay RG. Activation of c-myb by carboxy-terminal truncation: relationship to transformation of murine haemopoietic cells in vitro. EMBO J 1989;8:1777-1783.
114. Molawi K, Sieweke MH. Transcriptional control of macrophage identity, self-renewal, and function. Adv Immunol 2013;120:269-300.
115. Tillmanns S, et al. SUMO modification regulates MafB-driven macrophage differentiation by enabling Myb-dependent transcriptional repression. Mol Cell Biol 2007;27:5554-5564.
116. Hedge SP, Kumar A, Kurschner C, Shapiro LH. c-Maf interacts with c-Myb to regulate transcription of an early myeloid gene during differentiation. Mol Cell Biol 1998;18:2729-2737.
117. Aziz A, et al. Development of macrophages with altered actin organization in the absence of MafB. Mol Cell Biol 2006;26:6808-6818.
118. Sieweke MH, Tekotte H, Frampton J, Graf T. MafB is an interaction partner and repressor of Ets-1 that inhibits erythroid differentiation. Cell 1996;85:49-60.
119. Baumbach WR, Keath EJ, Cole MD. A mouse c-myc retrovirus transforms established fibroblast lines in vitro and induces monocyte-macrophage tumors in vivo. J Virol 1986;59:276-283.
120. Varlakhanova NV, et al. Myc maintains embryonic stem cell pluripotency and self-renewal. Differentiation 2010;80:9-19.
121. Cartwright P, McLean C, Sheppard A, Rivett D, Jones K, Dalton S. LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism. Development 2005;132:885-896.
122. Jiang J, et al. A core Klf circuitry regulates self-renewal of embryonic stem cells. Nat Cell Biol 2008;10:353-360.
123. Hall J, et al. Oct4 and LIF/Stat3 additively induce Krüppel factors to sustain embryonic stem cell self-renewal. Cell Stem Cell 2009;5:597-609.
124. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663-676.
125. Nakagawa M, et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 2008;26:101-106.
126. Wernig M, Meissner A, Cassady JP, Jaenisch R. c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell 2008;2:10-12.
127. Graeber MB, Tetzlaff W, Streit WJ, Kreutzberg GW. Microglial cells but not astrocytes undergo mitosis following rat facial nerve axotomy. Neurosci Lett 1988;85:317-321.
128. Solomon JN, Lewis C-AB, Ajami B, Corbel SY, Rossi FMV, Krieger C. Origin and distribution of bone marrow-derived cells in the central nervous system in a mouse model of amyotrophic lateral sclerosis. Glia 2006;53:744-753.
129. Ajami B, Bennett JL, Krieger C, McNagny KM, Rossi FMV. Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool. Nat Neurosci 2011;14:1142-1149.
130. Robbins CS, et al. Local proliferation dominates lesional macrophage accumulation in atherosclerosis. Nat Med 2013;19:1166-1172.
131. Franklin RA, et al. The cellular and molecular origin of tumor-associated macrophages. Science 2014;344:921-925.
132. Noy R, Pollard JW. Tumor-associated macrophages: from mechanisms to therapy. Immunity 2014;41:49-61.
133. Chao MP, Weissman IL, Majeti R. The CD47-SIRPα pathway in cancer immune evasion and potential therapeutic implications. Curr Opin Immunol 2012;24:225-232.
134. Prinz M, Priller J, Sisodia SS, Ransohoff RM. Heterogeneity of CNS myeloid cells and their roles in neurodegeneration. Nat Neurosci 2011;14:1227-1235.
135. Swirski FK, Nahrendorf M. Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure. Science 2013;339:161-166.
136. Randolph GJ. Mechanisms that regulate macrophage burden in atherosclerosis. Circ Res 2014;114:1757-1771.
137. Schulz C, Massberg S. Atherosclerosis-multiple pathways to lesional macrophages. Sci Transl Med 2014;6:239 ps2.
138. Odegaard JI, Chawla A. Pleiotropic actions of insulin resistance and inflammation in metabolic homeostasis. Science 2013;339:172-177.
139. Pittet MJ, Nahrendorf M, Swirski FK. The journey from stem cell to macrophage. Ann N Y Acad Sci 2014;1319:1-18.
140. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011;144:646-674.
141. Palma MD, Lewis CE. Macrophage regulation of tumor responses to anticancer therapies. Cancer Cell 2013;23:277-286.
142. Jose MD, Le Meur Y, Atkins RC, Chadban SJ. Blockade of macrophage colony-stimulating factor reduces macrophage proliferation and accumulation in renal allograft rejection. Am J Transplant 2003;3:294-300.
143. Swirski FK, et al. Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. J Clin Invest 2007;117:195-205.
144. Swirski FK, et al. Monocyte accumulation in mouse atherogenesis is progressive and proportional to extent of disease. Proc Natl Acad Sci USA 2006;103:10340-10345.
145. Gordon D, Reidy MA, Benditt EP, Schwartz SM. Cell proliferation in human coronary arteries. Proc Natl Acad Sci USA 1990;87:4600-4604.
146. Lutgens E, De Muinck ED, Kitslaar PJEHM, Tordoir JHM, Wellens HJJ, Daemen MJAP. Biphasic pattern of cell turnover characterizes the progression from fatty streaks to ruptured human atherosclerotic plaques. Cardiovasc Res 1999;41:473-479.
147. Randolph GJ. Proliferating macrophages prevail in atherosclerosis. Nat Med 2013;19:1094-1095.
148. Amano SU, et al. Local proliferation of macrophages contributes to obesity-associated adipose tissue inflammation. Cell Metab 2014;19:162-171.
149. Zhang Q, et al. Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature. PLoS ONE 2012;7:e50946.
150. Qian B-ZZ, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell 2010;141:39-51.
151. Ruffell B, Affara NI, Coussens LM. Differential macrophage programming in the tumor microenvironment. Trends Immunol 2012;33:119-126.
152. Overmeire E, Van Laoui D, Keirsse J, Ginderachter JA, Van Sarukhan A. Mechanisms driving macrophage diversity and specialization in distinct tumor microenvironments and parallelisms with other tissues. Front Immunol 2014;5:127.
153. Radtke F, MacDonald HR, Tacchini-Cottier F. Regulation of innate and adaptive immunity by Notch. Nat Rev Immunol 2013;13:1-11.
154. Joshi I, et al. Notch signaling mediates G1/S cell-cycle progression in T cells via cyclin D3 and its dependent kinases. Blood 2009;113:1689-1698.
155. Weng AP, et al. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 2004;306:269-271.
156. Andersson ER, Lendahl U. Therapeutic modulation of Notch signalling - are we there yet? Nat Rev Drug Discov 2014;13:357-378.
157. Moellering RE, et al. Direct inhibition of the NOTCH transcription factor complex. Nature 2009;462:182-188.
158. Yamasaki R, et al. Differential roles of microglia and monocytes in the inflamed central nervous system. J Exp Med 2014;211:1533-1549.
159. Heidt T, et al. Differential contribution of monocytes to heart macrophages in steady-state and after myocardial infarction. Circ Res 2014;115:284-295.